Defining the mechanisms that regulate VEGF expression in GBM cells has important implications for understanding tumor progression, thereby providing clinically relevant information that might suggest strategies for blocking angiogenesis in the pathogenesis of GBM tumors. This evidence concerns the gene VEGFA and glioblastoma.